These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16886724)

  • 1. Effects of risperidone on auditory information processing in neuroleptic-naive patients with schizophrenia spectrum disorders.
    Korostenskaja M; Dapsys K; Siurkute A; Maciulis V; Ruksenas O; Kähkönen S
    Acta Neurobiol Exp (Wars); 2006; 66(2):139-44. PubMed ID: 16886724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of risperidone on event-related potentials in schizophrenic patients.
    Iwanami A; Okajima Y; Isono H; Shinoda J; Kasai K; Hata A; Fukuda M; Nakagome K; Kamijima K
    Pharmacopsychiatry; 2001 Mar; 34(2):73-9. PubMed ID: 11302567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of olanzapine on auditory P300 and mismatch negativity (MMN) in schizophrenia spectrum disorders.
    Korostenskaja M; Dapsys K; Siurkute A; Maciulis V; Ruksenas O; Kähkönen S
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):543-8. PubMed ID: 15866356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory and visual P300 reflecting cognitive improvement in patients with schizophrenia with quetiapine: a pilot study.
    Park EJ; Han SI; Jeon YW
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):674-80. PubMed ID: 20304022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ERPs changes during neuroleptic treatment in schizophrenia--a vulnerability marker in schizophrenia].
    Asato N; Hirayasu Y; Hiramatsu K; Ohta H
    Seishin Shinkeigaku Zasshi; 1999; 101(3):254-76. PubMed ID: 10375977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.
    Adler LE; Olincy A; Cawthra EM; McRae KA; Harris JG; Nagamoto HT; Waldo MC; Hall MH; Bowles A; Woodward L; Ross RG; Freedman R
    Am J Psychiatry; 2004 Oct; 161(10):1822-8. PubMed ID: 15465979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.
    Hong X; Chan RC; Zhuang X; Jiang T; Wan X; Wang J; Xiao B; Zhou H; Jiang L; Weng B
    Schizophr Res; 2009 Mar; 108(1-3):151-7. PubMed ID: 19106034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
    Riedel M; Spellmann I; Strassnig M; Douhet A; Dehning S; Opgen-Rhein M; Valdevit R; Engel RR; Kleindienst N; Müller N; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):360-70. PubMed ID: 17629731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auditory evoked potentials as possible predictors of outcome in schizophrenic outpatients.
    Hegerl U; Gaebel W; Gutzman H; Ulrich G
    Int J Psychophysiol; 1988 Aug; 6(3):207-14. PubMed ID: 2900230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of medication history on midlatency auditory evoked responses in schizophrenia.
    Erwin RJ; Shtasel D; Gur RE
    Schizophr Res; 1994 Feb; 11(3):251-8. PubMed ID: 7910754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
    Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S
    CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
    Stefánsson SB; Jónsdóttir TJ
    Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in auditory P3 event-related potential in schizophrenia and depression.
    Blackwood DH; Whalley LJ; Christie JE; Blackburn IM; St Clair DM; McInnes A
    Br J Psychiatry; 1987 Feb; 150():154-60. PubMed ID: 2888501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching patients with stable schizophrenia or schizoaffective disorder from olanzapine to risperidone long-acting injectable.
    Rosa F; Schreiner A; Thomas P; Sherif T
    Clin Drug Investig; 2012 Apr; 32(4):267-79. PubMed ID: 22339430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effectiveness of flexibly dosed paliperidone extended-release: comparison among patients with schizophrenia switching from risperidone and other antipsychotic agents.
    Kim EY; Chang SM; Shim JC; Joo EJ; Kim JJ; Kim YS; Ahn YM
    Curr Med Res Opin; 2013 Oct; 29(10):1231-40. PubMed ID: 23777311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of risperidone on serum homocysteine levels in first-episode, drug-naïve patients with schizophrenia.
    Fan N; Tan Y; Yang F; Tian L; Chen S; Li J; Wang Z; Zhang X
    Neurosci Lett; 2017 May; 650():168-173. PubMed ID: 28419824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia.
    Keefe RS; Young CA; Rock SL; Purdon SE; Gold JM; Breier A;
    Schizophr Res; 2006 Jan; 81(1):1-15. PubMed ID: 16202565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of risperidone on spatial working memory in first-episode schizophrenia.
    Reilly JL; Harris MS; Keshavan MS; Sweeney JA
    Arch Gen Psychiatry; 2006 Nov; 63(11):1189-97. PubMed ID: 17088499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and Long-term Memantine Add-on Treatment to Risperidone Improves Cognitive Dysfunction in Patients with Acute and Chronic Schizophrenia.
    Schaefer M; Sarkar S; Theophil I; Leopold K; Heinz A; Gallinat J
    Pharmacopsychiatry; 2020 Jan; 53(1):21-29. PubMed ID: 31390660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clozapine on auditory event-related potentials in schizophrenia.
    Umbricht D; Javitt D; Novak G; Bates J; Pollack S; Lieberman J; Kane J
    Biol Psychiatry; 1998 Oct; 44(8):716-25. PubMed ID: 9798075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.